Karyopharm Therapeutics Ownership | Who Owns Karyopharm Therapeutics?
Karyopharm Therapeutics Ownership Summary
Karyopharm Therapeutics is owned by 50.86% institutional investors, 6.29% insiders, and 42.84% retail investors. T. rowe price investment management is the largest institutional shareholder, holding 8.45% of KPTI shares. T. Rowe Price Small-Cap Value is the top mutual fund, with 5.17% of its assets in Karyopharm Therapeutics shares.
KPTI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Karyopharm Therapeutics | 50.86% | 6.29% | 42.84% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 307.00% | 11.11% | -218.12% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| T. rowe price investment management | 728.77K | 8.45% | $3.14M |
| Adage capital partners gp | 421.32K | 4.89% | $1.82M |
| Blackrock | 4.17M | 3.61% | $3.62M |
| Eversept partners, lp | 257.15K | 2.98% | $1.11M |
| Blackrock funding, inc. /de | 236.64K | 2.75% | $1.02M |
| Palo alto investors lp | 187.91K | 2.18% | $809.90K |
| Avidity partners management lp | 134.57K | 1.56% | $579.98K |
| Marshall wace, llp | 128.45K | 1.49% | $553.62K |
| Renaissance | 1.20M | 0.96% | $813.31K |
| Silverback asset management | 70.00K | 0.81% | $301.70K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Birchview capital, lp | 419.83K | 0.23% | $283.93K |
| Palo alto investors lp | 187.91K | 0.17% | $809.90K |
| Avidity partners management lp | 134.57K | 0.12% | $579.98K |
| Eversept partners, lp | 257.15K | 0.10% | $1.11M |
| Silverback asset management | 70.00K | 0.04% | $301.70K |
| Ikarian capital | 27.26K | 0.02% | $117.48K |
| Adage capital partners gp | 421.32K | 0.00% | $1.82M |
| Xtx topco | 13.06K | 0.00% | $56.27K |
| T. rowe price investment management | 728.77K | 0.00% | $3.14M |
| Renaissance | 1.20M | 0.00% | $813.31K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 728.77K | 0.00% | 589.12K |
| Susquehanna group, llp | 664.14K | 0.00% | 361.60K |
| Palo alto investors lp | 187.91K | 0.17% | 187.91K |
| Alyeska investment group | 144.51K | 0.00% | 144.51K |
| Bank of america corp /de/ | 298.69K | - | 140.77K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | - | - | -7.65M |
| Blackrock | 4.17M | 0.00% | -5.28M |
| Exome asset management | - | - | -2.00M |
| State street | 453.81K | - | -1.83M |
| Gsa capital partners llp | - | - | -1.60M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Palo alto investors lp | 187.91K | 0.17% | 187.91K | $809.90K |
| Xtx topco | 13.06K | 0.00% | 13.06K | $56.27K |
| Baird financial group | 10.53K | 0.00% | 10.53K | $45.39K |
| Raymond james financial | 90.00 | - | 90.00 | $388.00 |
| Fortitude family office | 81.00 | 0.00% | 81.00 | $349.00 |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -6.00 |
| Farther finance advisors | -13.00 |
| Nelson, van denburg & campbell wealth management group | -22.00 |
| Nisa investment advisors | -50.00 |
| Financial gravity asset management | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 52 | 4.00% | 4,384,528 | -15.32% | 50 | 281.78% | 27 | 575.00% | 7 | -83.33% |
| Mar 31, 2025 | 51 | -45.74% | 5,312,129 | -91.28% | 4 | 0.17% | 4 | -88.89% | 43 | 86.96% |
| Dec 31, 2024 | 92 | -4.17% | 60,468,438 | 1.78% | 48 | 2.14% | 34 | 13.33% | 24 | -22.58% |
| Sep 30, 2024 | 96 | -20.00% | 59,409,677 | -12.02% | 47 | 1.39% | 31 | -41.51% | 31 | -6.06% |
| Jun 30, 2024 | 120 | - | 67,526,761 | -9.69% | 58 | 1.36% | 53 | -7.02% | 33 | 6.45% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Small-Cap Value | 446.29K | 5.17% | -522.00 |
| T. Rowe Price U.S. SC Value Eq Tr-D | 263.68K | 3.05% | 213.59K |
| Vanguard US Total Market Shares ETF | 3.42M | 2.71% | -1.00 |
| Vanguard Total Stock Mkt Idx Inv | 223.22K | 2.58% | -4.88K |
| Vanguard Explorer Inv | 133.88K | 1.55% | - |
| C WorldWide Healthcare Select 1A | 100.00K | 1.16% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 80.72K | 0.93% | -36.78K |
| AlphaCentric LifeSci Healthcare I | 1.13M | 0.90% | - |
| AlphaCentric Life Sciences & Hlthcare I | 1.13M | 0.89% | - |
| Kennedy Micro Cap | 1.03M | 0.81% | -22.77K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 29, 2025 | Poulton Stuart | EVP, Chief Development Officer | Sell | $834.67 |
| Jul 22, 2025 | Abate Kristin | Chief Accounting Officer | Sell | $952.00 |
| May 06, 2025 | Paulson Richard A. | President and CEO | Sell | $1.68K |
| Apr 23, 2025 | Rangwala Reshma | EVP & Chief Medical Officer | Sell | $2.59K |
| Apr 04, 2025 | Paulson Richard A. | President and CEO | Sell | $916.30 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 2 |
| 2025 Q2 | - | 3 |
| 2025 Q1 | - | 4 |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 7 |
KPTI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools